Want to see IN:NURECA full AI Analyst Report?
NURECA Stock Chart & Stats
₹298.85
-₹10.75(-3.41%)
At close: 4:00 PM EST
₹298.85
-₹10.75(-3.41%)
Day’s Range― - ―
52-Week Range₹200.10 - ₹375.00
Previous CloseN/A
Volume68.50K
Average Volume (3M)990.00
Market Cap
₹3.18B
Enterprise Value₹1.56B
Total Cash (Recent Filing)₹130.23M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)80.4
Beta1.13
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.38%
Share Statistics
EPS (TTM)4.12
Shares Outstanding9,541,920
10 Day Avg. Volume686
30 Day Avg. Volume990
Financial Highlights & Ratios
PEG Ratio0.66
Price to Book (P/B)1.13
Price to Sales (P/S)1.39
P/FCF Ratio116.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Recovery And ProfitabilityThe return to revenue growth and two consecutive profitable years indicate that the business has regained operating traction after earlier weakness. If this recovery persists, it can improve reinvestment capacity and provide a more stable base for expanding the company’s home healthcare product portfolio.
Very Low Financial LeverageA conservatively financed balance sheet reduces interest and refinancing pressure while preserving flexibility to fund inventory, marketing, and product development. Low leverage is particularly valuable because it gives Nureca more capacity to absorb earnings volatility without relying heavily on additional borrowing.
Owned Health And Wellness Product PortfolioThe owned-brand portfolio spans recurring consumer health needs, from monitoring devices to physiotherapy products, while online and retail distribution broadens customer access. This category breadth and channel reach can support repeat product launches and reduce reliance on a single device or use case.
Bears Say
Thin Profitability MarginsVery thin net and operating margins leave limited protection against discounts, platform fees, logistics costs, returns, or changes in product mix. Even with revenue growth, small cost increases or pricing pressure could materially reduce earnings, limiting the durability of current profitability.
Volatile Earnings And Revenue HistoryThe uneven revenue and earnings record makes it difficult to treat the recent recovery as a settled long-term trend. Such volatility can complicate inventory planning, marketing commitments, and investment decisions, while increasing the risk that future growth does not translate consistently into profits.
Weak And Inconsistent Cash ConversionPositive cash flow in FY2026 is encouraging, but low conversion from profit and the prior year’s cash burn show that reported earnings have not consistently become usable cash. Continued volatility could constrain internally funded growth and increase working-capital execution risk.
Nureca Ltd. News
NURECA FAQ
What was Nureca Ltd.’s price range in the past 12 months?
Nureca Ltd. lowest stock price was ₹200.10 and its highest was ₹375.00 in the past 12 months.
What is Nureca Ltd.’s market cap?
Nureca Ltd.’s market cap is ₹3.18B.
When is Nureca Ltd.’s upcoming earnings report date?
Nureca Ltd.’s upcoming earnings report date is Nov 05, 2026 which is in 22 days.
How were Nureca Ltd.’s earnings last quarter?
Nureca Ltd. released its earnings results on Jul 21, 2026. The company reported ₹3.214 earnings per share for the quarter.
Is Nureca Ltd. overvalued?
According to Wall Street analysts Nureca Ltd.’s price is currently Overvalued.
Does Nureca Ltd. pay dividends?
Nureca Ltd. pays a Semiannually dividend of ₹3 which represents an annual dividend yield of 0.38%. See more information on Nureca Ltd. dividends here
What is Nureca Ltd.’s EPS estimate?
Nureca Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nureca Ltd. have?
Nureca Ltd. has 9,541,920 shares outstanding.
What happened to Nureca Ltd.’s price movement after its last earnings report?
Nureca Ltd. reported an EPS of ₹3.214 in its last earnings report. Following the earnings report the stock price went up 3.564%.
Which hedge fund is a major shareholder of Nureca Ltd.?
Currently, no hedge funds are holding shares in IN:NURECA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nureca Ltd.
Operating in India, Nureca Limited is a business-to-consumer (B2C) firm specializing in home healthcare and general wellness solutions. Their extensive product portfolio addresses various health needs, encompassing items for managing chronic conditions like nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers. They also provide orthopedic aids such as massagers, pain monitoring devices, posture correctors, and rehabilitation equipment. Further offerings include humidifiers and steamers, personal weighing scales, yoga and exercise accessories, fitness trackers, and dental and personal hygiene essentials. Additionally, Nureca caters to mother and infant care with products like baby feeding accessories, carry cots, baby skincare items, and bottle warmers/sterilizers. They also supply nutritional supplements, weight management aids, and advanced monitoring devices such as ECG machines, activity trackers, and smart scales. These diverse offerings are marketed under their proprietary brands: Dr Trust, Dr Physio, and Trumom. Distribution occurs through a multi-channel approach, utilizing third-party e-commerce platforms, a network of distributors and retailers, as well as their direct-to-consumer website, drtrust.in. Established in 2016, Nureca Limited is headquartered in Chandigarh, India.
Technical Analysis
Amrutanjan Health Care Limited
―
Blue Jet Healthcare Limited
―
Procter & Gamble Health Ltd.
―
Sanofi Consumer Healthcare India Limited
―
Zota Health Care Ltd.
―








